Ultrasound for the Heart / Powerful Breakthrough Introduced by Arrow International Lowers Anesthesia Risks

Reading, Pa. (PROTEXT) - Patients at risk under anesthesia cansignificantly lower their chances of developing extensivecomplications with the help of a new application of ultrasound.Called the HemoSonic(TM) 100, this noninvasive, powerful toolprobes the body's main artery without touching it. TheHemoSonic(TM) 100 was the subject of two presentations today atthe 1999 American Society of Anesthesiologists (ASA) Convention,Dallas Convention Center in Dallas, TX. (Photo: http://www.newscom.com/cgi-bin/prnh/19990928/PHTU014 ) Ultrasound for the heart Using beams of high-frequency sound waves much like asubmarine's sonar system, a monitoring system from ArrowInternational targets the body's biggest artery, the aorta,without ever touching it, tipping doctors off to potential heartand stroke-related occurrences in non-cardiac surgery orintensive care. The system makes its "home base" inside the patient's foodpassageway, the esophagus, where a small probe using ultrasoundsurveys the adjacent aorta to help calculate blood flow in real-time. With this knowledge in hand, anesthesiologists, internistsand cardiologists can precisely interpret changes in blood flow,as well as the heart's ability to pump blood includingresistances to blood flow and left ventricular performance --then administer the appropriate follow-up therapy. Jean-Luc Boulnois, co-developer of the HemoSonic(TM) 100(initially invented at Institut National de la Sante et de laRecherche Medicale (INSERM) states, "Doctors liken the powerfultool to an early warning device that can detect tissue or bloodflow abnormalities immediately as they occur a priceless benefitfor patients who develop problems during surgery that aresometimes brought on by the effects of anesthesia." In Europeand Japan, the technique has been used successfully in more than6,000 patients. Arrow International is a worldwide manufacturer and marketerof innovative, clinically advanced, cost-effective medicaldevices and other health care products used in critical care andcardiac care procedures. Its primary focus is to provideinnovative solutions for medical professionals in the areas ofcardiac care, critical care and implantable devices. For further information on the HemoSonic(TM) 100 andinnovative medical product technologies, contact Zane Szurgot,R.N., M.S.N., Arrow International, 800-233-3187 or 610-378-0131.ots Original Text Service: Arrow International Internet:http://www.newsaktuell.de Contact: Zane Szurgot of ArrowInternational, 800-233-3187, or 610-378-0131, or Trish Doll ofPublicity Works, 717-445-6377, for Arrow International Photo:NewsCom: http://www.newscom.com/cgi-bin/prnh/19990928/PHTU014

PRN Photo Desk, 888-776-6555 or 201-369-3467 Video:http://www.videonewswire.com/play?video=1999100811 Web site:http://www.arrowintl.com

Subscribers please note that material bearing the slug"PROTEXT" is not part of CTK's news service and is not to bepublished under the "CTK" slug. Protext is a commercial serviceproviding distribution of press releases from clients, who areidentified in the text of Protext reports and who bear fullresponsibility for their contents.

PROTEXT